Introduction {#Sec1}
============

Endotracheal intubation with mechanical ventilation (MV) support is an important intervention for managing patients with respiratory failure in the intensive care unit (ICU). After the respiratory condition has stabilized and the patient has been successfully weaned from MV, removal of the endotracheal tube removal (extubation) is scheduled. However, 2--16% of patients on MV undergo potentially life-threatening unplanned extubation (UE), which is defined as an accidental or a patient-induced removal of an endotracheal tube^[@CR1]--[@CR6]^. UE can cause several serious complications: aspiration pneumonia, bronchospasm, arrhythmia, respiratory failure, or even sudden cardiac arrest^[@CR7]--[@CR10]^. Furthermore, patients who undergo UE will have their MV, ICU stay, and hospital stay prolonged^[@CR6],\ [@CR11]--[@CR13]^. The hospital mortality rate of patients who undergo UE can range from 10% to 25%, and even higher for patients who require reintubation^[@CR6],\ [@CR12],\ [@CR14],\ [@CR15]^. Although many studies^[@CR2],\ [@CR8],\ [@CR9],\ [@CR11],\ [@CR12],\ [@CR16]--[@CR19]^ have mentioned UE-associated mortality, most of them focus on a comparison of mortality rates between patients who do and do not undergo UE. Some studies^[@CR8],\ [@CR11],\ [@CR16],\ [@CR19]^ have reported that UE is associated with a higher mortality rate, but others^[@CR9],\ [@CR12],\ [@CR17],\ [@CR18]^ have reported contrary findings. In the present study, we retrospectively reviewed the outcomes of patients who underwent UE in a medical center's ICUs and calculated their mortality risk.

Methods {#Sec2}
=======

Study design and patient selection {#Sec3}
----------------------------------

A retrospective review of the medical records of all medical and surgical adult patients, including those in the 96 beds in Chi Mei's 6 ICUs, who underwent UE between 2009 and 2015 was done in Chi Mei Medical Center. We calculated only the data of first UE for patients who underwent more than one UE during the same admission.

In our ICU, we would opiate agents including fentanyl or morphine as analgesia and benzodiazepines, including midazolam, lorazepam or propofol as sedative agents to keep patients being not agitated and comfortable according to the sedative protocol (appendix 1)^[@CR15]^. Additionally, haloperidol can be prescribed for delirium and muscle relaxant including pancuronium or atracurium can be added if the above treatment failed. In addition, a weaning protocol was applied for the patients with acute respiratory failure ready for weaning (appendix 2). We also has set up a multidisciplinary team as physical therapist, respiratory therapist, critical care nurse and family to initiate the 4-level early mobilization program to improve the MV patients outcomes since April 1 2014^[@CR20]^. In January 2014, the AnchorFast Guard tube fastener was applied to replace adhesive tape and cloth tape ties, as to well secure oral endotracheal tube. After the clinical condition improved and hemodynamic status became stable, we use pressure support ventilation for starting weaning and T-piece might be used. Extubation required acute weaning and the extubation protocol, or an order by an intensivist. Extubation was considered successful if reintubation was not required within the subsequent 48 hours. The reasons for re-intubating patients within 48 hours (failed extubation) included excessive secretions, acute respiratory distress with stridor, oxygenation failure, encephalopathy, and hemodynamic instability.

Measurements {#Sec4}
------------

In this study, we collected the following data: (1) demographic and clinical variables: age, gender, cause of respiratory failure (cardiac, pulmonary, neurologic, gastrointestinal, hepatic, renal, and others), cause of reintubation, the duration of intubation before UE, and ICU type (medical or surgical); (2) disease severity: Acute Physiology and Chronic Health Evaluation (APACHE) II score, TISS score and GCS; (3) respiratory parameter and the result of laboratory examinations before extubation, such as respiratory rate (RR), the setting of ventilatior (positive end expiratory pressure \[PEEP\], tidal volume \[TV\] and etc.); and (4) outcomes: the UE rate (UE episodes per 100 ventilated patients), the failed UE rate (ratio of reintubation within 48 hours/100 UE), length of stay in ICU and hospital, total medical costs, and in-hospital mortality. The primary endpoint was factors that predicted mortality. The data were retrospectively collected and then analyzed. Therefore, informed consent was specifically waived and the study was approved by the Institutional Review Board of Chi Mei Medical Center (IRB: 10601-005).

Statistical analyses {#Sec5}
--------------------

The comparison between non-survivors and survivors were examined using independent-samples *t* test for variables which were normally distributed and Mann-Whiney U test and χ^2^ test for those which were not. If *P* \< 0.05, it was defined statistically significant. The variable with statistical significance in univariate analysis (*P* \< 0.05), were further regarded as a focused risk factor of morality in the logistic regression model. SPSS 20.0 for Windows (SPSS, Inc., Chicago, IL, USA) was used for all analyses.

Results {#Sec6}
=======

Between January 1, 2009, and December 31, 2015, there were 305 episodes of UE in 295 ICU patients. Because we only enrolled the first episode of UE for analysis, the first episodes of 295 patients were taken into further analysis. Forty-five patients died (mortality rate: 15.3%) (Table [1](#Tab1){ref-type="table"}). One hundred ninety-nine patients (67.5%) were men (mean age = 65.7 years; age range = 18--94 years). The average APACHE II score was 16.4, TISS score was 26.5, and GCS score was 10.4. The average duration between time of intubation and UE was 134.4 ± 158.9 hours. One hundred thirty-six (46.1%) patients reintubated within 48 hours. Stroke (n = 93 \[31.5%\]) and diabetes mellitus (n = 73 \[24.8%\]) were the two most common comorbidities. Non-survivors had significantly higher APACHE II and TISS scores, medical originated patients, a higher reintubation rate, more comorbidities, and more uremia, liver cirrhosis, and cancer than did survivors.Table 1Demographic and clinical variables of the different unplanned extubation (UE) groups.ItemAll patients (n = 295)Non-survivors (n = 45)Survivors (n = 250)*p* valueAge (years)65.7 ± 16.1 (18\~94)68.0 ± 14.665.4 ± 16.30.317^a^Female patients96 (32.5%)11 (24.4%)85 (34.0%)0.208Body mass index23.7 ± 4.5 (13.8\~41.3)24.0 ± 5.023.6 ± 4.40.591APACHE II score16.4 ± 8.7 (3\~42)22.9 ± 8.715.2 ± 8.1\<0.001TISS26.5 ± 9.1 (10\~56)30.3 ± 10.725.9 ± 8.60.015^a^Glasgow Coma Scales10.3 ± 4.1 (3\~15)9.4 ± 4.510.5 ± 4.00.129^a^Intubation by pulmonary cause112 (38.0%)22 (48.9%)90 (36.0%)0.101Time of MV before UE (h)134.4 ± 158.9 (0\~1231)165.2 ± 239.7128.8 ± 139.30.680^a^Re-intubation within 48 h136 (46.1%)34 (75.6%)102 (40.8%)\<0.001Medical origin154 (52.2%)32 (71.1%)122 (48.8%)0.004Endotracheal intubation278 (94.2%)45 (100%)233 (93.2%)0.118Self-extubation189 (64.1%)27 (60.0%)162 (64.8%)0.537Co-morbidity1.0 ± 1.01.4 ± 1.11.0 ± 1.00.009 Coronary artery disease71 (24.1%)10 (22.2%)61 (24.4%)0.753 COPD42 (14.2%)6 (13.3%)36 (14.4%)0.850 Uremia23 (7.8%)12 (26.7%)11 (4.4%)\<0.001 Liver cirrhosis14 (4.7%)9 (20.0%)5 (2.0%)\<0.001 Diabetes73 (24.7%)16 (35.8%)57 (22.8%)0.068 Stroke93 (31.5%)10 (22.8%)83 (33.2%)0.145 Cancer24 (8.1%)8 (17.8%)16 (6.4%)0.017Expressed as mean ± SD (range) or n (%); APACHE II = Acute Physiology and Chronic Health Evaluation; TISS = Therapeutic Intervention Score System; COPD = chronic obstructive pulmonary disease. ^a^The Mann-Whiney U test was used owing to not being normally distributed.

We compared the laboratory results before UE between the non-survivors and survivors (Table [2](#Tab2){ref-type="table"}). Non-survivors had significant higher respiratory rates, higher FiO~2~ requirements, higher PEEP levels, and higher BUN and creatinine levels than did survivors. In contrast, survivors had significantly higher PaO~2~/FiO~2~, hemoglobin, hematocrit, and albumin levels than did non-survivors. Additionally, the timings of UE, the episodes of agitation, and need for and use of sedatives medications were not significantly different between survivors and non-survivors. Finally, non-survivors were prescribed and took lorazepam significantly more frequently than did survivors. Survivors also had a higher percentage of weaning stats (defined as the use of pressure support mode with a pressure level ≤14 cm H~2~O) than did non-survivors.Table 2Most recent data before extubation of different unplanned extubation (UE) groups.ItemAll patients (n = 295)Non-survivors (n = 45)Survivors (n = 250)*p* valueMean arterial pressure (mmHg)98.0 ± 17.7 (50\~153)93.9 ± 23.098.8 ± 16.50.185Heart rate (beats/min)92.4 ± 17.1 (52\~152)95.0 ± 19.091.9 ± 16.70.365^a^Respiratory rate (/min)17.6 ± 5.7 (7\~36)19.3 ± 6.117.3 ± 5.50.026Arterial blood gas data pH7.43 ± 0.06 (7.13\~7.59)7.40 ± 0.097.44 ± 0.050.015 PaO~2~ (mmHg)107.7 ± 56.1 (24\~506)104.6 ± 65.2108.3 ± 54.50.695 FiO~2~ (%)31.5 ± 12.7 (21\~100)36.8 ± 19.130.2 ± 10.20.029 PaO~2~/FiO~2~ (mmHg)346.9 ± 131.9 (24\~506)313.8 ± 170.7352.9 ± 123.00.152 PaCO~2~ (mmHg)37.1 ± 8.3 (15.8\~75.7)36.7 ± 9.537.1 ± 8.10.802 Tidal volume (mL)508.6 ± 152.1 (209\~1458)501.3 ± 132.3510.0 ± 155.70.542^a^ PEEP (cmH~2~O)5.9 ± 1.6 (0\~14)7.1 ± 2.25.6 ± 1.4\<0.001Biochemistry data Hb10.9 ± 2.0 (5.0\~18.0)10.2 ± 2.511.1 ± 1.80.012^a^ Hct33.5 ± 7.0 (5.1\~52.3)31.0 ± 8.733.9 ± 6.60.013 BUN31.3 ± 23.5 (3\~163)48.7 ± 35.328.1 ± 19.1\<0.001^a^ Creatinine1.9 ± 2.5 (0.4\~26.2)2.7 ± 2.21.8 ± 2.50.024 Sodium139.3 ± 6.3 (112.4\~161.3)138.6 ± 8.4139.4 ± 5.90.542 Potassium3.9 ± 0.5 (2.6\~5.9)3.9 ± 0.63.8 ± 0.50.713 Calcium7.9 ± 0.9 (1.2\~12.4)8.0 ± 1.07.9 ± 0.90.579^a^ Phosphate3.6 ± 1.8 (1.3\~12.4)4.2 ± 2.43.5 ± 1.60.292^a^ Albumin2.7 ± 0.7 (0.9\~4.4)2.4 ± 0.72.8 ± 0.70.003UE shift0.234 Day time102 (34.7%)14 (31.3%)88 (35.2%) Evening time112 (38.0%)14 (31.1%)98 (39.2%) Night time81 (27.5%)17 (37.8%)64 (25.6%)Agitation95 (32.2%)13 (28.9%)82 (32.8%)0.605Sedatives100 (33.9%)17 (37.8%)83 (33.2%)0.550Use of Lorazepine24 (8.1%)9 (20.0%)15 (6.0%)0.005Weaning status159 (53.9%)12 (26.7%)147 (58.8%)\<0.001Expressed as mean ± SD (range) or n (%). ^a^The Mann-Whiney U test was used owing to not being normally distributed.

Non-survivors had non-significantly longer hospital stays, and higher hospital costs than did survivors. Non-survivors had significantly longer ICU stays than did survivors (Table [3](#Tab3){ref-type="table"}). Multivariate analyses showed five risk factors---respiratory rate, APACHE II score, uremia, liver cirrhosis, and weaning stats---independently associated with mortality in UE patients (Table [4](#Tab4){ref-type="table"}).Table 3Outcomes of different unplanned extubation groups.ItemAll patients (n = 295)Non-survivors (n = 45)survivors (n = 250)*p* valueICU stay (days)14.7 ± 13.9 (1\~127)21.3 ± 21.713.5 ± 11.70.006^a^Hospital stay (days)36.1 ± 27.1 (1\~206)39.7 ± 37.635.5 ± 24.80.924^a^Hospital cost (NTD,  × 10^4^)55.8 ± 45.7 (2.1\~558.5)67.9 ± 86.341.7 ± 35.90.004^a^Expressed as mean ± SD (range); NTD = new Taiwan dollars. ^a^The Mann-Whiney U test was used owing to not being normally distributed. Table 4Mortality predictors of unplanned extubation using logistic regression model.VariablesOdds ratio95% confidence interval*p* valueLowerUpper**APACHE II1**.**0581**.**0061**.**1140**.**028**Comorbidity1.2470.8551.8210.252**Uremia5**.**8111**.**56621**.**5590**.**009Liver cirrhosis5**.**9201**.**46323**.**960**.**013Respiratory rate** (/**min**)**1**.**0921**.**0141**.**1760**.**020**pH0.030019.1660.288FiO~2~ (%)1.0060.9771.0360.694PEEP (cmH2O)1.1430.8981.4540.277Hct0.9770.9191.0390.457Creatinine0.9500.7771.1620.620Albumin0.6850.3511.3370.268**Weaning status0**.**3880**.**1560**.**9660**.**042**n = 295

Discussion {#Sec7}
==========

We found that a higher respiratory rate before UE, higher APACHE II score, uremia, liver cirrhosis, and not in the process of being weaned were independently associated with increased mortality in patients with UEs. This is consistent with the findings of other ICU studies. One Korean study^[@CR21]^ reported the association between hospital mortality and reintubation, chronic neurological disease, emergency surgery, and higher APACHE II scores in UE patients in a surgical ICU. In addition, we found that a higher respiratory rate before extubation was associated with a higher risk of death in UE patients. This is because patients with tachypnea just before UE are not good candidates for extubation; thus, their mortality risk might be higher. In contrast, the mortality was significantly lower in UE patients being weaned before extubation. Our previous study showed that the rate of liberation form MV over 48 hours among UE patients were higher in those MV modes were setting in weaning condition (62.7%) as compared to those who were not (37.7%), and those successful weaning UE patients certainly had a significantly lower in-hospital mortality than failed UE patients (11.1% vs. 23.1%)^[@CR15]^. Because these patients should be ready for extubation, if it occurs a little earlier than anticipated, it might not affect outcome. In addition, we has conducted an early mobilization program since April 1 2014^[@CR20]^, and it may help to restore the muscle power during the critical phase, shorten the MV days and set patients ready for weaning. Those can partially help explain UE patients under weaning trial have a better outcome.

Uremia patients usually have multiple comorbidities and are prone to develop acute organ failure and in-hospital mortality. Our previous study displayed that the uremia patients had a significantly higher incidence of mortality than non-uremia patients among patients with acute respiratory failure requiring MV (342.30 vs. 179.67 per 1000 person-years, adjusted hazard ratio of 1.43)^[@CR22]^. In this study, we have the similar finding that uremia was associated with higher risk of death among patients with UE.

Liver cirrhosis, in adults worldwide has become the 14^th^ most common cause of death, with an average year mortality of 1.03 million deaths^[@CR23]^. In patients with decompensated liver cirrhosis, they would be accompanied with variceal bleeding, ascites, peritonitis, hepatorenal syndrome and hepatopulmonary syndrome. We previously showed that among critically ill patients with MV, those who with liver cirrhosis had more organ failures and had a significantly lower survival rate than non-cirrhosis controls (adjusted hazard ratio of 1.38)^[@CR24]^. Similarly, the present study exhibited that cirrhosis could predict hospital mortality after the occurrence of UE.

More than 90% of our UE patients survived to discharge. This finding might imply that the extubation, planned and unplanned, of some patients in this study was delayed. Despite the weaning and extubation protocols of the six ICUs, the final decision to extubate could also be made by intensivists; therefore, it was possible to delay extubation. Finally, delayed extubation might have led to a relatively lower mortality rate in this study.

One recent review^[@CR25]^ reported that reintubation rates range from 1.8% to 88% in UE patients. We found that 136 (46.1%) patients required reintubation within 48 hours after UE, and that the mortality rate of UE patients who required reintubation was higher than for patients who did not: 25.0% (34/136) vs. 6.9% (11/159). This is consistent with previous studies^[@CR14],\ [@CR20],\ [@CR26]^. Overall, reintubation was associated with poorer outcomes in UE patients.

Other studies^[@CR25],\ [@CR27],\ [@CR28]^ have reported several risk factors of UE: male gender, higher APACHE scores (≥17), chronic obstructive pulmonary disease, restlessness and agitation, lower sedation levels, higher consciousness levels, taking midazolam, and needing physical restraints. This is consistent with our findings on gender, the mean APACHE II score, agitation, and sedation.

This study had one major limitation: it was conducted in a single medical center. There might be differences about weaning and extubation decisions between our hospital and others. Therefore, our findings might not be generalizable to other hospitals. Additional large-scale studies are warranted to confirm our findings. In addition, we find that tachypnea prior to UE is a significant finding that predicts mortality. There are many reasons for tachypnea and since the paCO2 is not significant between groups, it is obviously not indicative of ventilation failure. Also, we did not show the tidal volume in ml/kg, as it might help to give an indicator as to their method of ventilation and determine if it is appropriate. Further survey is necessary to confirm these conclusions.

In conclusion, we found that a higher respiratory rate before UE, higher APACHE II score, uremia, liver cirrhosis, and not in the process of being weaned were risk factors associated with increased mortality in UE patients.
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